Showing results (1-10 of 372) with videos related to
Sort By:
Pageof 38
Proteomics|February 2, 2018
Proteomics with Mass Spectrometry Imaging: Beyond Amyloid TypingFrancesca Lavatelli, Giampaolo MerliniExpert Review of Proteomics|September 29, 2016
Advances in proteomic study of cardiac amyloidosis: progress and potentialFrancesca Lavatelli, Giampaolo MerliniProteomics. Clinical Applications|November 28, 2012
Clinical proteomics for diagnosis and typing of systemic amyloidosesFrancesca Brambilla, Francesca Lavatelli, Giampaolo Merlini, et al.Eupa Open Proteomics|June 15, 2018
Systemic amyloidoses and proteomics: The state of the artFrancesca Lavatelli, Andrea di Fonzo, Giovanni Palladini, et al.Clinical Chemistry and Laboratory Medicine|May 30, 2014
Biochemical markers in early diagnosis and management of systemic amyloidosesFrancesca Lavatelli, Riccardo Albertini, Andrea Di Fonzo, et al.Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
Treatment of IgM-associated AL amyloidosis with the combination of rituximab, bortezomib, and dexamethasoneGiovanni Palladini, Andrea Foli, Paola Russo, et al.Journal of Proteome Research|October 3, 2013
Shotgun protein profile of human adipose tissue and its changes in relation to systemic amyloidosesFrancesca Brambilla, Francesca Lavatelli, Dario Di Silvestre, et al.Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 4, 2012
Changes in tissue proteome associated with ATTR amyloidosis: insights into pathogenesisFrancesca Brambilla, Francesca Lavatelli, Veronica Valentini, et al.Clinical Chemistry and Laboratory Medicine|June 17, 2009
Proteomics in protein misfolding diseasesMonica Stoppini, Laura Obici, Francesca Lavatelli, et al.Haematologica|September 18, 2012
A phase II trial of cyclophosphamide, lenalidomide and dexamethasone in previously treated patients with AL amyloidosisGiovanni Palladini, Paola Russo, Paolo Milani, et al.Pageof 38